Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/24381967
Conclusion of this study
Among patients with mild to moderate AD, 2000 IU/d of alpha tocopherol compared with placebo resulted in slower functional decline. There were no significant differences in the groups receiving memantine alone or memantine plus alpha tocopherol. These findings suggest benefit of alpha tocopherol in mild to moderate AD by slowing functional decline and decreasing caregiver burden.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study